Chapter 12 PERITONEAL DIALYSIS
|
|
- Jeffery Jordan
- 5 years ago
- Views:
Transcription
1 Chapter 12 PERITONEAL DIALYSIS B. Sunita A/P V. Bavanandan Anita Bhajan Manocha Lily Binti Mushahar Mohamad Zaimi Bin Abdul Wahab Sudhaharan Sivathasan
2 PERITONEAL DIALYSIS 22nd Report of the SECTION 12.1: MODALITIES AND PRESCRIPTION OF PD (TABLES ) The number of patients treated with Peritoneal Dialysis (PD) in Malaysia has grown by approximately 2.7 times over the last decade where the prevalence of PD patients as of 31st December has increased from 1174 in the year 2005 to 3149 patients for the year PD therapy overall comprises 9.4 of the total number of dialysis patients (Table (b)). The bulk of PD therapy (81.3) remains in the form of Continuous Ambulatory Peritoneal Dialysis (CAPD). Automated Peritoneal Dialysis (APD) utilization has increased from a mere 3.6 in 2005 to the present level of However, in the last five years the growth of APD has ceased (Table ). There has been an increased utilization of the Fresenius Medical Care (FMC) system, with the ratio of FMC to Baxter approaching 1:3 by 2014 (Table ). The majority of patients on CAPD (91.5) are using 4 exchanges per day, while 81.8 of those on APD are using total dwell volumes of 10L per day (Tables12.1.3a and Table b). In CAPD, the majority of patients (65) practice self care but in APD, the largest proportion (66) are either completely or partially assisted. In terms of age distribution, it is clear PD is the preferred modality in the paediatric age groups where for ages 1-14 years, 78 of new patients start PD, for those aged 15 to 24 years it is approximately one-quarter and in the young working age group of years, one-fifth choose PD (Tables12.1.5(a) and (b)). There are no significant gender differences in choice of PD therapy (Tables (a) and (b)). Table : Peritoneal dialysis regimes, PD regime n n n N n Standard CAPD DAPD AutomatedPD/ CCPD TOTAL PD regime n n n N n Standard CAPD DAPD AutomatedPD/ CCPD TOTAL
3 22nd Report of the PERITONEAL DIALYSIS Table : CAPD connectology, CAPD connectology n n n N n Baxter disconnect Fresenius disconnect Others TOTAL CAPD connectology n n n N n Baxter disconnect Fresenius disconnect Others TOTAL Table a: CAPD Number of Exchanges per day, Number of exchanges/ day n n n n n N TOTAL Number of exchanges/ day n n n N n TOTAL Table b: APD dwell volumes per day, Dwell volumes/ day n n n N n TOTAL Dwell volumes/ day n n n N n TOTAL
4 PERITONEAL DIALYSIS 22nd Report of the Table : Assistance to Perform PD, PD regime/assistance n n n N n CAPD Self care Partial self care Completely assisted Unknown Automated PD Self care Partial self care Completely assisted Unknown PD regime/assistance n n n N n CAPD Self care Partial self care Completely assisted Unknown Automated PD Self care Partial self care Completely assisted Unknown Figure (a): Assistance to Perform CAPD, Self-care completely assisted Partial Self-care Unknown Figure (b): Assistance to Perform APD, Self-care completely assisted Partial Self-care Unknown Percent () Percent () CAPD APD 160
5 22nd Report of the PERITONEAL DIALYSIS Table (a): PD Treatment Rate by Age Group, per million age group population Age groups (years) Table (b): Percentage Age Distributionof PD Patients Year n n n n N n n n n N New Dialysis patients years years years years years years >=65 years Dialysing at 31 st December years years years years years years >=65 years Where = PD / HD+PD The numbers in table for incident and prevalent pts are reversed - pl correct Table (a): PD Treatment Rate by Gender, per million male or female population Gender Male Female
6 PERITONEAL DIALYSIS 22nd Report of the Table (b): Gender Distributionof PD Patients n n n n n n n n N n New PD patient Male Female PD at 31 st December Male Female n = PD count only = PD / HD+PD SECTION 12.2: ACHIEVEMENT OF SOLUTE CLEARANCE AND PERITONEAL TRANSPORT The percentage of patients achieving target solute clearance of 1.7 per week showed a further decline to 74 in 2014 (Table ).The figure had been static at 79 from with a slight drop to 78 in This should prompt some work to be done in identifying the causes for the declining rate. Wide inter-centre variation for delivered Kt/v was still seen in The proportion of patients achieving the delivered Kt/v varied from 47 to 89 5 th, 95 th percentiles) (Table ). Perhaps the PD practices in the better performing centres can be evaluated and shared with less well performing centres. The majority of the new PD patients had a low average and high average peritoneal membrane transport status with 39.3 and 33.4 respectively (Table ). Interestingly, most patients had a low average and high average membrane transport status even with 5 and 10 years dialysis vintage (Table ). As expected, residual urine volume showed a steady decline over time (Table and Figure ). However, on a positive note, up to a third of patients have a residual urine volume more than 400 ml/day after 4 or more years on PD ( Table ) Table : Distribution of delivered Kt/V, PD patients Year Numberof Patients Mean SD Median LQ UQ patients 1.7 per week
7 22nd Report of the PERITONEAL DIALYSIS Figure : Cumulative distribution of delivered Kt/V, PD patients Cumulative distribution Kt/V Figure : Variation in proportion of patients with Kt/V > 1.7 per week among PD centres patients with Kt/V >=1.7 per week (lower 95 CI, upper 95 CI) Centre Table : Variation in proportion of patients with Kt/V > 1.7 per week among PD centres, Year Number of centres Min 5 th Centile LQ Median UQ 95 th Centile Max Table : Peritoneal transport status by PET D/P creatinine at 4 hours, new PD patients Year n n n n n n n n n n Low Low average High average High TOTAL
8 PERITONEAL DIALYSIS 22nd Report of the Table : Peritoneal Transport Status (PET) with dialysis vintage Duration (Years) <1 1 <2 2 <3 3 <4 4 <5 n n n n n Low Low average High average High TOTAL Duration (Years) 5 <6 6 <7 7 <8 8 <9 9 <10 10 or more n n n n n n Low Low average High average High TOTAL Table : Residual Urine Volume Duration (Years) <1 1 <2 2 <4 4 or more n n n n <100 ml <400 ml <800 ml <1000 ml >=1000 ml TOTAL Figure : Residual Urine Volume in prevalent PD patients (2014) 100 <100 mls 100-<400 mls 400-<800 mls 800-<1000 mls >=1000 mls 80 Percent () <1 1-<2 2-<4 >=4 Duration (Years) 164
9 22nd Report of the PERITONEAL DIALYSIS SECTION 12.3: TECHNIQUE SURVIVAL ON PD There was no difference in technique survival (uncensored and censored for death and transplant) between the and time periods (Table and Figure a & b). In the latter period, technique survival was 93, 78 and 72 at 1, 3 and 4 years respectively (censored for death and transplant). The youngest age group (age <14 years) had better technique survival (uncensored for death and transplant) (Table & Figure a). However, after censoring for death and transplant, the age group 65 years fared best compared to other age groups after 3 years on PD treatment (Table & Figure b). Females consistently had better technique survival than their male counterparts (Table and Figure a & b). The technique survival (uncensored for death and transplant) was better for non-diabetic patients (Table & Figure a) but the difference was lost on censoring for death and transplant (Table & Figure b). There was a clear association between technique survival and solute clearance. Patients with Kt/V <1.7 had the worst technique survival. There was no initial difference in technique survival between Kt/V and Kt/V >2.0 but the curves started to diverge at 36 months, with better outcome in Kt/V >2.0 (Table & Figure ). Age group years, a history of peritonitis, male gender, obesity, low hemoglobin, low serum albumin, low serum calcium and low serum phosphate were associated with an increased risk of change in modality of renal replacement therapy (Table ). The commonest cause of PD drop out in year 2014 was peritonitis (13) followed by membrane failure (6) as shown in Table and Figure (a). Majority of the technique failure (72) occurred after 12 months of treatment (Table b). Table (a): Unadjusted technique survival by era and (uncensored for death and transplant) Era Interval (month) N SE N SE
10 PERITONEAL DIALYSIS 22nd Report of the Table (b): Unadjusted technique survival by era and (censored for death and transplant) Era Interval (month) N SE N SE Figure a: Unadjusted technique survival by era and (uncensored for death and transplant) Kaplan-Meier survival estimates, by Era Figure (b): Unadjusted technique survival by era and (censored for death and transplant) Kaplan-Meier survival estimates, by Era Cumulative survival Year Year Cumulative survival Year Year Duration in months Duration in months Table (a): Unadjusted technique survival by age (uncensored for death and transplant) Age group (years) Interval (month) n <= SE n SE n SE n SE 166
11 22nd Report of the PERITONEAL DIALYSIS Age group (years) Interval (month) n >=65 SE n SE N SE Table (b): Unadjusted technique survival by age (censored for death and transplant) Age group (years) Interval (month) n <= SE n SE n SE n SE Age group (years) Interval (month) n >=65 SE n SE N SE 167
12 PERITONEAL DIALYSIS 22nd Report of the Figure (a): Unadjusted technique survival by age (uncensored for death and transplant) Figure (b): Unadjusted technique survival by age (censored for death and transplant) 1.00 Kaplan-Meier survival estimates, by Age 1.00 Kaplan-Meier survival estimates, by Age Age 1-14 Cumulative survival Age Age Age Age>=65 Age 1-14 Age Age Duration in months Cumulative survival Age Age Age Age>=65 Age Age Duration in months Table (a): Unadjusted technique survival by gender (uncensored for death and transplant) Gender Interval (months) Male Female N survival SE N survival SE Figure (a): Unadjusted technique survival by gender (uncensored for death and transplant) Figure (b): Unadjusted technique survival by gender (censored for death and transplant) 1.00 Kaplan-Meier survival estimates, by sex 1.00 Kaplan-Meier survival estimates, by sex Cumulative survival Male Female Cumulative survival Male Female Duration in months Duration in months 168
13 22nd Report of the PERITONEAL DIALYSIS Table (b): Unadjusted technique survival by gender (censored for death and transplant) Gender Interval (months) Male Female n survival SE N survival SE Table (a): Unadjusted technique survival by diabetes status (uncensored for death and transplant), Diabetes status Interval (month) Non diabetic Diabetic N survival SE N survival SE Figure (a): Unadjusted technique survival by Diabetes status (uncensored for death and transplant) Figure (b): Unadjusted technique survival by diabetes status (censored for death and transplant) 1.00 Kaplan-Meier survival estimates, by Diabetes 1.00 Kaplan-Meier survival estimates, by Diabetes Cumulative survival Non-diabetic Cumulative survival Diabetic Non-diabetic Diabetic Duration in months Duration in months 169
14 PERITONEAL DIALYSIS 22nd Report of the Table (b): Unadjusted technique survival by diabetes status (censored for death and transplant) Diabetes status Interval (month) Non diabetes Diabetic n survival SE N survival SE Table : Unadjusted technique survival by Kt/V, Kt/V Interval (months) < >2. 0 n SE N SE N SE Figure : Unadjusted technique survival by Kt/V, Kaplan-Meier survival estimates, by KTV Kt/V Cumulative survival Kt/V >2.0 Kt/V < Duration in months 170
15 22nd Report of the PERITONEAL DIALYSIS Table : Adjusted hazard ratio for change of modality, Factors n Hazardratio 95CI p value Age (years) Age 1 14 (ref*) Age (1.079;2.234) Age (0.766;1.663) Age (0.834;1.778) Age (0.700;1.468) Age (0.706;1.471) Age >= (0.646;1.425) Peritonitis No (ref*) Yes (8.090;10.590) <0.001 Diabetes Mellitus Non diabetic (ref*) Diabetic (0.851;1.161) Gender Male (ref*) Female (0.611;0.819) <0.001 Cardiovascular Disease No CVD (ref*) CVD (0.776;1.164) BMI < (0.698;1.131) <25 (ref*) >= (1.178;1.565) <0.001 Serum Albumin < (1.058;1.507) < (0.938;1.269) <45 (ref*) >= (0.393;1.622) Serum cholesterol (mmol/l) < (0.682;1.328) < (0.641;0.928) < (0.779;1.154) >=6.2 (ref*) Diastolic BP <70 70 <80 80 <90 (ref*) 90 <100 >=100 Hemoglobin (g/dl) <10 10 <12 (ref*) >=12 Serum calcium (mmol/l) < <=2.37 (ref*) > (0.808;1.363) (0.881;1.208) (0.983;1.442) (1.048;2.469) (1.197;1.590) < (0.713;1.178) (1.007;1.373) (0.838;1.200)
16 PERITONEAL DIALYSIS 22nd Report of the Factors n Hazardratio 95CI p value Calcium Phosphate product < (0.848;1.254) <4.5 (ref*) < (0.531;0.921) >= (0.605;1.414) Serum Phosphate (mmol/l) < (2.198;7.211) < <1.3 (ref*) < (0.684;0.984) < (0.622;1.111) >= (0.860;2.002) Kt/V < (0.904;1.301) (ref*) <= (0.995;1.366) Assisted PD Selfcare (ref*) Assisted (0.854;1.165) Table (a): Reasons for drop-out from PD program, Year n n n n n n N n n n Death Transplant Peritonitis Catheter related infection Membrane failure Technical problem Patient preference Others Unknown TOTAL
17 22nd Report of the PERITONEAL DIALYSIS Figure (a): Reasons for drop-out from PD program, Death Peritonitis Membrane failure Patient preference Unknown Transplant Catheter related infection Technical problem Others 100 Percent () Table (b): Drop-out rate from PD program with time on treatment, Year n n n n n n n n n n < 3 months <6 months 6 <12 months >=12 months TOTAL Table : Time on PD ( ) Months 1st Treatment (n=7316) 0 <
18 PERITONEAL DIALYSIS 22nd Report of the SECTION 12.4: PERITONITIS The median peritonitis rate for the year 2014 was 42.9 patient-months per episode (Table ). While this is a good result as compared to ISPD standards, there is a worsening trend for peritonitis rates in 2013 and 2014 compared to the achievemtents in 2011 and This may be due to an increased number of newer PD units over the last 2 years. There was a wide inter-centre variation at 67.6 versus 34 patient-months per episode. There was a similar incidence of gram positive (32.9) and gram negative peritonitis (31.8) (Table (a)). The commmonest gram positive pathogens were Staphylococcus aureus and Staphylococcus coagulase negative while Escherichia coli and Klebsiella were the main gram negative organisms isolated. Rates of fungal and mycobacterial peritonitis were very low, i.e. 2.2 and 0.8 respectively. Culture negative rates remain high at 25.6, although the rates in are slightly improved compared the earlier 5-year period Gram positive peritonitis showed better recovery rate compared to gram negative infections in both eras (Figures of (a) and (b)). Amongst the gram negative infections, Pseudomonas has the worst prognosis with only reported complete resolution and nearly one third resulting in catheter removal. The death rate was highest with fungal or Mycobacterial peritonitis. Comparing year vs, Streptococcal, Klebsiella and Polymicrobial organisms showed obvious improvement in peritonitis outcome in the latter era. In the era, polymicrobial peritonitis had a better resolution rate than in the previous era (51 versus 36) resulting in a lower death rate (23 compared to 43) (Figure c). The improvements in resolution of peritonitis were also noted with Streptococcal and Klebsiella peritonitis in year. Factors that significantly contributed to a lower risk of peritonitis were younger age group (age less than 14 years) and higher income group (Table ). The elderly age group (>55 years) and assisted PD (partially or complete) were shown to have a higher risk of developing peritonitis. Table : Variation in peritonitis rate (pt-month/epi) among PD centres, Year Number of centres Min 5 th Centile LQ Median UQ 95 th Centile Max
19 22nd Report of the PERITONEAL DIALYSIS Figure : Variation in peritonitis rate among PD centres, 2014 Rate, pt-month/epi Peritonitis rate (lower 95 CI, upper 95 CI) Centre Table (a): Causative organism in PD peritonitis, (A) Gram Positives N n n n n n n n n n Staph. aureus Staph Coagulase Neg Strep Others (B) Gram Negatives Pseudomonas Acinetobacter Klebsiella Enterobacter E.Coli Others (C) Polymicrobial (D) Others Fungal Mycobacterium Others (E) No growth TOTAL
20 PERITONEAL DIALYSIS 22nd Report of the Figure (b) Causative organism in PD peritonitis, Frequency Staph. Aureus Other Gram positive E.Coli Fungal Culture Negative Staph Coagulase Neg. Pseudomonas Polymicrobial Mycobacterium Table (a): Outcome of peritonitis by causative organism, Outcome Resolved Not resolved,catheter removed Death Total n N n n (A) Gram Positives Staph. Aureus Staph Coagulase Neg Strep Others (B) Gram Negatives Pseudomonas Acinetobacter Klebsiella Enterobacter E.Coli Others (C) Polymicrobial (D) Others Fungal Mycobacterium Others (E) No growth
21 22nd Report of the PERITONEAL DIALYSIS Table (b): Outcome of peritonitis by causative organism, Outcome Resolved Not resolved,catheter removed Death Total n N n n (A) Gram Positives Staph. aureus Staph coagulase neg Strep Others (B) Gram Negatives Pseudomonas Acinetobacter Klebsiella Enterobacter E.coli Others (C) Polymicrobial (D) Others Fungal Mycobacterium Others (E) No growth Figure (a): Outcome of peritonitis by causative organism, Figure (b): Outcome of peritonitis by causative organism, Resolved Not resolved, catheter removed Death Resolved Not resolved, catheter removed Death Percent () Percent () Staph. Aureus Staph Coagulase Neg. Strep Others Pseudomonas Acinetobacter Klebsiella Enterobacter E.Coli Others Polymicrobial Fungal Mycobacterium Others No growth 0 Staph. Aureus Staph Coagulase Neg. Strep Others Pseudomonas Acinetobacter Klebsiella Enterobacter E.Coli Others Polymicrobial Fungal Mycobacterium Others No growth Causative organism 177
22 PERITONEAL DIALYSIS 22nd Report of the Figure (c): Comparison of peritonitis outcome by causative organism by era, & Resolved Not resolved, catheter removed Death 100 Percent () Staph. Aureus Staph Coagulase Neg. Strep Others Pseudomonas Acinetobacter Klebsiella Enterobacter E.Coli Causative organism by era Others Polymicrobial Fungal Mycobacterium Others No growth Outcome of peritonitis by causative organism by era Table : Risk factors influencing peritonitis rate, Factors n Risk Ratio 95 CI P value Age (years) <= (0.664;0.986) (0.806;1.116) (ref*) (0.946; 1.263) (0.906;1.195) (1.028;1.357) >= (0.993;1.348) Gender Male (ref*) Female (0.963;1.103) Diabetes No (ref*) Yes (0.961;1.115) Income <RM 1000 (ref*) RM (0.758; 0.875) <0.001 RM (0.548;0.700) <0.001 RM (0.350;1.101) >=RM (0.122;1.958) Education Nil (0.914;1.189) Primary (0.930;1.090) Secondary (ref*) Tertiary (0.861;1.105) Assistance to perform CAPD Self care (ref*) Partially assisted (1.019;1.235) Completely assisted (1.058;1.261)
CHAPTER 12. Peritoneal Dialysis
23rd Report of the PERITONEAL DIALYSIS CHAPTER 12 Peritoneal Dialysis Sunita Bavanandan Anita Bhajan Manocha Lily Mushahar Mohamad Zaimi Bin Abdul Wahab PERITONEAL DIALYSIS 23rd Report of the SECTION 12.1:
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Rosnawati Yahya
CHAPTER 5 Editor: Dr Rosnawati Yahya Expert Panels: Dr Rosnawati Yahya Dr Ng Kok Peng Dr Suryati Binti Yakaob Dr Mohd Zaimi Abd Wahab Dr Yee Seow Ying Dr Wong Hin Seng Contents 5. Stock and Flow of Renal
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr Goh Bak Leong Expert Panel: Dr Goh Bak Leong (Chair) Dato Dr Zaki Morad Mohd Zaher Dato Dr (Mr) Rohan Malek Dr Fan Kin Sing Dr Lily Mushahar Dr Lim Soo Kun Dr
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr Goh Bak Leong Expert Panel: Dr Goh Bak Leong (Chair) Dato Dr (Mr) Rohan Malek Dr Wong Hin Seng Dr Fan Kin Sing Dr Rosnawati Yahya Dr S Prasad Menon Dr Tan Si
More informationCHAPTER 6 PERITONEAL DIALYSIS
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Hannah Dent Kylie Hurst Stephen McDonald PERITONEAL DIALYSIS ANZDATA Registry 11 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to
More informationCHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst 212 Annual Report 35th Edition PERITONEAL DIALYSIS ANZDATA Registry 212 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis
More informationChapter 5 PAEDIATRIC RENAL REPLACEMENT THERAPY. Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin
Chapter 5 PAEDIATRIC RENAL REPLACEMENT THERAPY Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin SECTION A: RRT PROVISION FOR PAEDIATRIC PATIENTS This chapter presents
More informationCHAPTER 5. Paediatric Renal Replacement Therapy
24th Report of the CHAPTER 5 Paediatric Renal Replacement Therapy Lee Ming Lee Lim Yam Ngo Lynster Liaw Chiew Tung Susan Pee Yap Yok Chin Wan Jazilah Wan Ismail 24th Report of the SECTION A: RRT PROVISION
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Rosnawati Yahya. Expert Panels: Hooi Lai Seong Ng Kok Peng Suryati Binti Yakaob Wong Hin Seng.
CHAPTER 5 Editor: Roswati Yahya Expert Panels: Hooi Lai Seong Ng Kok Peng Suryati Binti Yakaob Wong Hin Seng Contents 5. Stock and Flow of Rel Transplantation Stock and Flow Transplant Rates 5.2 Recipients
More informationCHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition
CHAPTER 6 Neil Boudville Hannah Dent Stephen McDonald Kylie Hurst Philip Clayton 213 Annual Report - 36th Edition ANZDATA Registry 213 Report STOCK AND FLOW AUSTRALIA Peritoneal dialysis was used to treat
More informationCHAPTER 14. Renal Transplantation
15th Report of the Malaysian RENAL TRANSPLANTATION CHAPTER 14 Renal Transplantation Editor: Dr. Goh Bak Leong Expert Panel: : Dato Dr. Dato Zaki Dr. Morad Zaik Morad Mohd (Chair) Zaher (Chair) Dr. Goh
More informationYou can sleep while I dialyze
You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep
More informationCHAPTER 5 RENAL TRANSPLANTATION
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan Kin Sing Dr. Lily Mushahar Mr. Rohan Malek Dr. S. Prasad
More informationPD In Acute Kidney Injury. February 7 th -9 th, 2013
PD In Acute Kidney Injury February 7 th -9 th, 2013 Objectives PD as a viable initial therapy PD in AKI PD versus dhd PD versus CVVHD Why not PD first PD for AKI Early days (1970 s) PD was the option of
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More information3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane
3/21/2017 Solute Clearance and Adequacy Targets in Peritoneal Dialysis Steven Guest MD Director, Medical Consulting Services Baxter Healthcare Corporation Deerfield, IL, USA Peritoneal Membrane Image courtesy
More informationAna Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto
Ana Paula Bernardo CHP Hospital de Santo António ICBAS/ Universidade do Porto Clinical relevance of hyperphosphatemia Phosphate handling in dialysis patients Phosphate kinetics in PD peritoneal phosphate
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationPERITONEAL EQUILIBRATION TEST. AR. Merrikhi. MD. Isfahan University of Medical Sciences
PERITONEAL EQUILIBRATION TEST AR. Merrikhi. MD. Isfahan University of Medical Sciences INTRODUCTION The peritoneal equilibration test (PET) is a semiquantitative assessment of peritoneal membrane transport
More informationmorbidity & mortality
morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related
More informationChapter 7: Adequacy of Haemodialysis and Serum Bicarbonate
Chapter 7: Adequacy of Haemodialysis and Serum Bicarbonate Summary. The urea reduction ratio (URR) has been rising year on year but now appears to have reached a plateau.. The URR increases the longer
More informationChapter 2 Peritoneal Equilibration Testing and Application
Chapter 2 Peritoneal Equilibration Testing and Application Francisco J. Cano Case Presentation FW, a recently diagnosed patient with CKD Stage 5, is a 6-year-old boy who has been recommended to initiate
More informationImad Ahmed MD. Renal Associates of West Michigan
Imad Ahmed MD Renal Associates of West Michigan ESRD Facts: - Medicare funded program - Cost - Significant mortality and morbidity - Reduced quality of life - Shrinking donor pool ESRD CAUSES - DM - Hypertension
More informationMicrobiology Risk Factors and Outcomes of Peritonitis in Tunisian Peritoneal Dialysis Patients
Original Article World J Nephrol Urol. 2018;7(2):45-52 Microbiology Risk Factors and Outcomes of Peritonitis in Tunisian Peritoneal Dialysis Patients Lilia Ben Lasfar a, b, Yosra Guedri a, Awatef Azzebi
More informationHaemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health
Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different
More informationTitle:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients
Author's response to reviews Title:Hyperphosphatemia as an Independent Risk Factor of Coronary Artery Calcification Progression in Peritoneal Dialysis Patients Authors: Da Shang (sdshangda@163.com) Qionghong
More informationReinitiation of peritoneal dialysis after catheter removal for refractory peritonitis
J Nephrol (2014) 27:445 449 DOI 10.1007/s40620-014-0048-1 ORIGINAL ARTICLE Reinitiation of peritoneal dialysis after catheter removal for refractory peritonitis R. Ram G. Swarnalatha K. V. Dakshinamurty
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 10: Dialysis Providers In 2013, collectively the three large dialysis organizations treated 71% of patients in 67% of all dialysis units. In the Small Dialysis
More informationPART FOUR. Metabolism and Nutrition
PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 22, 2006 Costas Fourtounas, Eirini Savidaki, Marilena Roumelioti, Periklis Dousdampanis, Andreas Hardalias, Pantelitsa Kalliakmani,
More informationPERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE
PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT GUIDE TABLE OF CONTENTS Introduction.... 3 SECTION 1: FUNDAMENTALS OF THE PRESCRIPTION.... 4 Getting Started: Patient Pathway to First Prescription.... 5 Volume
More informationChapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report
Chapter 12 End Stage Kidney Disease in Indigenous Peoples of and Aotearoa/ 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, the rates and practice patterns for end-stage
More informationCHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease
CHAPTER 2 Prevalence of Renal Replacement Therapy for End Stage Kidney Disease Summarising the number of prevalent renal replacement therapy patients in Australia and New Zealand, the prevalence rate per
More informationFistula First? Vascular Symposium 4/28/18
Fistula First? Vascular Symposium 4/28/18 Disclosure I have no financial interest to disclose connected to any of the information presented in this discussion Objectives Scope of Problem Benefits of PD
More informationWhat is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test
1 2 3 What is a PET? Although there are many types of pets, we will be discussing the Peritoneal Equilibration Test 4 Background information about the PET 1983 Dr. Twardowski and colleagues began measuring
More informationCHAPTER 4 METHOD AND LOCATION OF DIALYSIS. Nancy Briggs Kylie Hurst Stephen McDonald Annual Report 35th Edition
CHAPTER 4 METHOD AND LOCATION OF DIALYSIS Nancy Briggs Kylie Hurst Stephen McDonald 212 Annual Report 35th Edition METHOD AND LOCATION OF DIALYSIS ANZDATA Registry 212 Report AUSTRALIA Figure 4.1 Aust
More informationCHAPTER 13. Renal Transplanta on
CHAPTER 13 Renal Transplanta on Rosnawa Yahya Hooi Lai Seong Ng Kok Peng Surya Bin Yakaob Wong Hin Seng SECTION 13.1: STOCK AND FLOW The number of new transplant pa ents decreased from 151 in 26 to its
More informationPeritoneal Dialysis Prescriptions: A Primer for Nurses
Peritoneal Dialysis Prescriptions: A Primer for Nurses A Primer ABCs of PD R x Betty Kelman RN-EC MEd CNeph (C) Toronto General Hospital University Health Network Toronto, Ontario, Canada A moment to remember
More informationYeatsh CHAPTER. William Butler
Sickness brought me this Thought, in that scale his: Why should I be dismayed Though Lame had burned the whole World, as it were a coal, Now I have seen it weighed Against a soul? William Butler Yeatsh
More informationUnited States Renal Data System (USRDS) International Data Collection Form
United States Renal Data System (USRDS) International Data Collection Form This form is designed to solicit information on the population of End-Stage Renal Disease (ESRD) patients in your country who
More informationVariable Included. Excluded. Included. Excluded
Table S1. Baseline characteristics of patients included in the analysis and those excluded patients because of missing baseline serumj bicarbonate levels, stratified by dialysis modality. Variable HD patients
More informationPeritonitis is a major cause of morbidity and mortality
Proceedings of the First Asian Chapter Meeting ISPD December 13 15, 2002, Hong Kong Peritoneal Dialysis International, Vol. 23 (2003), Supplement 2 0896-8608/03 $3.00 +.00 Copyright 2003 International
More informationChapter six Outcomes: hospitalization & mortality. There is an element of death in life, and I am astonished
INTRODUCTION 1 OVERALL HOSPITALIZATION & MORTALITY 1 hospital admissions & days, by primary diagnosis & patient vintage five-year survival mortality rates, by patient vintage expected remaining lifetimes
More informationPichaya Tantiyavarong, 1,2 Opas Traitanon, 2 Piyatida Chuengsaman, 3 Jayanton Patumanond, 1 and Adis Tasanarong Introduction
International Nephrology Volume 2016, Article ID 6217135, 8 pages http://dx.doi.org/10.1155/2016/6217135 Research Article Dialysate White Blood Cell Change after Initial Antibiotic Treatment Represented
More informationChapter Five Clinical indicators & preventive health
Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being
More informationOUTCOME FOLLOWING CAPD-ASSOCIATED GRAM-NEGATIVE PERITONITIS
66 OUTCOME FOLLOWING CAPD-ASSOCIATED GRAM-NEGATIVE PERITONITIS CHIA-SHENG CHEN, SHYI-YU CHUNG, WEN-LIANG YU*, MING-TZUNG KAO Peritonitis remains the leading cause of patient dropout from peritoneal dialysis
More informationMETABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
METABOLISM AND NUTRITION WITH PD OBESITY Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 Body Size in Patients New to Dialysis United States Body Mass Index, kg/m2 33 31
More informationSmart APD prescription. Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong
Smart APD prescription Prof. Wai Kei Lo Tung Wah Hospital The University of Hong Kong Costing Comparison of Different Modes of RRT in Hong Kong in 2011 (Per Year) HK$300,000 HK$250,000 HK$200,000 HK$150,000
More informationAdvances in Peritoneal Dialysis, Vol. 23, 2007
Advances in Peritoneal Dialysis, Vol. 23, 2007 Antonios H. Tzamaloukas, 1,2 Aideloje Onime, 1,2 Dominic S.C. Raj, 2 Glen H. Murata, 1 Dorothy J. VanderJagt, 3 Karen S. Servilla 1,2 Computation of the Dose
More informationHyperphosphatemia is a strong predictor of overall
Peritoneal Phosphate Clearance is Influenced by Peritoneal Dialysis Modality, Independent of Peritoneal Transport Characteristics Sunil V. Badve,* Deborah L. Zimmerman,* Greg A. Knoll, * Kevin D. Burns,*
More informationA clinical audit to compare peritonitis rates between peritoneal dialysis delivery systems
A clinical audit to compare peritonitis rates between peritoneal dialysis delivery systems Lesley Williams, Clint Douglas, Ann Bonner, Nicola Williams & Dwarakanathan Ranganathan Submitted: 19 December
More informationPERITONEAL DIALYSIS CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006
PERITONEAL DIALYSIS CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 5 and 6] MAKE CORRECTIONS
More informationDialysis, personalized. More options for your patients well being.
Dialysis, personalized. More options for your patients well being. Discover the advanced peritoneal dialysis (PD) system with improved features for added control and convenience during your patients treatment
More informationIncreased peritoneal dialysis utilization and improved patient survival over a 20-year period: data from a Portuguese Peritoneal Dialysis Unit
ORIGINAL ARTICLE Port J Nephrol Hypert 2016; 30(2): 113-120 Advance Access publication 30 January 2016 Increased peritoneal dialysis utilization and improved patient survival over a 20-year period: data
More informationPatients with underlying liver disease and ascites are
Peritoneal Dialysis International, Vol. 26, pp. 213 217 Printed in Canada. All rights reserved. 0896-8608/06 $3.00 +.00 Copyright 2006 International Society for Peritoneal Dialysis CONTINUOUS AMBULATORY
More informationAJNT. Original Article
. 2012 May;5(2):81-6 Original Article AJNT Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis Sarra Elamin
More informationQQuickly take me up into the bright child of your mind. E.E. CUMMINGS, The Enormous Room
QQuickly take me up into the bright child of your mind. E.E. CUMMINGS, The Enormous Room msix PEDIATrIC ESrD 18 ž 21 ATLAS OF ESRD IN THE UNITED STATES Incident rates of ESRD in children have risen two
More informationCHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1
ANZDATA Registry 213 Report INDIGENOUS END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12 Stephen McDonald Matthew Jose Kylie Hurst 213 Annual Report - 36th Edition
More informationChapter 10: Dialysis Providers
Chapter 10: Dialysis Providers In 2014 the two largest dialysis organizations, Fresenius and DaVita, collectively treated 69% of patients in 65% of all dialysis units (Figure 10.2). Nearly 90% of all dialysis
More informationChapter Two Renal function measures in the adolescent NHANES population
0 Chapter Two Renal function measures in the adolescent NHANES population In youth acquire that which may restore the damage of old age; and if you are mindful that old age has wisdom for its food, you
More informationAdvances in Peritoneal Dialysis, Vol. 29, 2013
Advances in Peritoneal Dialysis, Vol. 29, 2013 Takeyuki Hiramatsu, 1 Takahiro Hayasaki, 1 Akinori Hobo, 1 Shinji Furuta, 1 Koki Kabu, 2 Yukio Tonozuka, 2 Yoshiyasu Iida 1 Icodextrin Eliminates Phosphate
More information5FM QFMUQ? AFGJB?Q FC PC?JJW GQ 5FM QCRQ FGK GL FGQ AMLQRCJJ?RGML?LB NSRQ RFC KC?QSPGLE PMB MD BGQR?LAC GL FGQ F?LB
AF?NRCP $"#/ pediatric end-stage renal disease 5FM QFMUQ? AFGJB?Q FC PC?JJW GQ 5FM QCRQ FGK GL FGQ AMLQRCJJ?RGML?LB NSRQ RFC KC?QSPGLE PMB MD BGQR?LAC GL FGQ F?LB -
More informationOriginal Articles. Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis
Nephrol Dial Transplant (2014) 29: 1940 1947 doi: 10.1093/ndt/gfu050 Advance Access publication 3 March 2014 Original Articles Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis
More informationThe role of automated peritoneal dialysis (APD) in an integrated dialysis programme
The role of automated peritoneal dialysis (APD) in an integrated dialysis programme Paul Williams*^, Linda Cartmel* and Jane Hollis^ *CAPD Unit, Ipswich Hospital, Ipswich, UK; 1CAPD Unit, Addenbrooke's
More informationFrom Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014
From Peritoneal Dialysis to Hemodialysis How could we improve the transition? Th Lobbedez CHU de Caen Self Dialysis Meeting 22 May 2014 Deux grands principes concernant la DP La dialyse péritonéale doit
More informationCHAPTER 2. Dialysis in Malaysia
15th Report of the Malaysian Dialysis and Transplant Registry 27 DIALYSIS IN MALAYSIA CHAPTER 2 Dialysis in Malaysia Lim Yam Ngo Lim Teck Onn Lee Day Guat 4 DIALYSIS IN MALAYSIA 15th Report of the Malaysian
More informationKIDNEY DIALYSIS FOUNDATION ANNUAL REPORT PERITONEAL DIALYSIS PROGRAMME
KIDNEY DIALYSIS FOUNDATION ANNUAL REPORT PERITONEAL DIALYSIS PROGRAMME 2011 Prepared by Dr Grace Medical Director With input from: Lay Kwee Chin Senior Nurse Clinician, Patient Services Theresa Soh Clinical
More informationTable 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use
Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)
More information. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less
Chapter 5: Joint Analyses with UK Transplant in England and Wales; Access to the Renal Transplant Waiting List, Time to Listing, Diabetic Access to Transplantation and the Influence of Social Deprivation
More informationPREDICTORS OF PERITONITIS AMONG CANADIAN PERITONEAL DIALYSIS PATIENTS
PREDICTORS OF PERITONITIS AMONG CANADIAN PERITONEAL DIALYSIS PATIENTS By Sharon J. Nessim, MD A thesis submitted in conformity with the requirements for the degree of Master of Science Graduate Department
More informationEnd Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand
Chapter 12 End Stage Kidney Disease Among Indigenous Peoples of and New Zealand 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, rates of end-stage kidney disease
More informationPrincess Alexandra Hospital, Brisbane
Princess Alexandra Hospital Coagulase Negative Staphylococcal Peritonitis in Australian Peritoneal Dialysis Patients Predictors, Treatment and Outcomes in 936 cases Dr Magid Fahim Princess Alexandra Hospital,
More informationANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)
ANNUAL REPORT 21 The Norwegian Renal Registry (Norsk Nefrologiregister) This report will also be available on: http://152.94.12.23/nyreforening/uremiregisteret/esdr.html Correspondence to: Overlege dr.med
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationPD prescribing for all. QUESTION: Which approach? One size fits all or haute couture? (1) or (2)? The patient 18/03/2014.
PD prescribing for all Pr Max Dratwa Honorary consultant, Nephrology-Dialysis CHU Brugmann Université Libre de Bruxelles BSN 22 March 2014 QUESTION: Which approach? One size fits all or haute couture?
More informationStatus of the CKD and ESRD treatment: Growth, Care, Disparities
Status of the CKD and ESRD treatment: Growth, Care, Disparities United States Renal Data System Coordinating Center An J. Collins, MD FACP Director USRDS Coordinating Center Robert Foley, MB Co-investigator
More informationChapter 2 End-Stage Renal Disease: Scope and Trends
Chapter 2 End-Stage Renal Disease: Scope and Trends Chapter 2 End-Stage Renal Disease: Scope and Trends END-STAGE RENAL DISEASE DEFINED The primary functions of the kidney are to remove waste products
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Mode of dialysis at initiation GUIDELINES
Date written: September 2004 Final submission: February 2005 Mode of dialysis at initiation GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More information02/21/2017. Assessment of the Peritoneal Membrane: Practice Workshop. Objectives. Review of Physiology. Marina Villano, MSN, RN, CNN
Assessment of the Peritoneal Membrane: Practice Workshop Marina Villano, MSN, RN, CNN marina.villano@fmc-na.com Objectives Briefly review normal peritoneal physiology including the three pore model. Compare
More informationDrug Use in Dialysis
(Last Updated: 08/22/2018) Created by: Socco, Samantha Drug Use in Dialysis Drambarean, B. (2017). Drug Use in Dialysis. Lecture presented at PHAR 503 Lecture in UIC College of Pharmacy, Chicago. DIALYSIS
More informationChapter 2. Prevalence of End Stage Kidney Disease. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015
Chapter 2 Prevalence of End Stage Kidney Disease 2016 ANZDATA Registry 39th Annual Report Data to 31-Dec-2015 Renal Replacement Therapy Table 2.1 shows the prevalence (pmp) of renal replacement therapy
More informationUW MEDICINE PATIENT EDUCATION. Peritoneal Dialysis. A treatment option for kidney disease. There are 2 types of PD: continuous ambulatory
UW MEDICINE PATIENT EDUCATION Peritoneal Dialysis A treatment option for kidney disease Class Goals 1. Understand the purpose and basic principles of continuous ambulatory peritoneal dialysis (CAPD). 2.
More informationPredictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran
Dialysis Predictors of Patient Survival in Continuous Ambulatory Peritoneal Dialysis 10-Year Experience in 2 Major Centers in Tehran Monir Sadat Hakemi, 1 Mehdi Golbabaei, 2 Amirahmad Nassiri, 3 Mandana
More informationThe Conundrum of First Dialysis Modality in Diabetic Patients with ESKD
The Conundrum of First Dialysis Modality in Diabetic Patients with ESKD Davide Bolignano, MD FERA National Research Council (CNR)Institute of Clinical Physiology Reggio Calabria, Italy Worldwide prevalence
More informationWhy NxStage? 4th self-care dialysis symposium 6th & 7th June 2018 Brussels. Page 1
Why NxStage? 4th self-care dialysis symposium 6th & 7th June 2018 Brussels Page 1 Are you prepared? 4.1% Annual increase 1 in European dialysis patients Reference: 1. 2017 USRDS Annual Data Report Reference
More informationGambrosol Trio, clinical studies 91 Glitazone, malnutrition-inflammationatherosclerosis
Subject Index Acidosis, see Metabolic acidosis Activated carbon, sorbents 337 Adipokines adipose tissue and systemic inflammation 169 functions 167 169 prospects for study in renal patients 171 Adiponectin,
More informationIN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2001
IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2001 [Before completing please read instructions at the bottom of this page and on pages 4 and 5] PATIENT IDENTIFICATION MAKE
More informationTHERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
THERAPEUTIC INTERVENTIONS TO PRESERVE RESIDUAL KIDNEY FUNCTION Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 2 Outline of Presentation Refinements in our understanding
More informationPredictive Factors for Withdrawal from Peritoneal Dialysis: A Retrospective Cohort Study at Two Centers in Japan
Advances in Peritoneal Dialysis, Vol. 33, 2017 Yasuhiro Taki, 1 Tsutomu Sakurada, 2 Kenichiro Koitabashi, 2 Naohiko Imai, 1 Yugo Shibagaki 2 Predictive Factors for Withdrawal from Peritoneal Dialysis:
More informationRenal Association Clinical Practice Guideline on peritoneal dialysis in adults and children
Woodrow et al. BMC Nephrology (2017) 18:333 DOI 10.1186/s12882-017-0687-2 CORRESPONDENCE Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children Graham Woodrow 1*, Stanley
More informationKIDNEY DIALYSIS FOUNDATION ANNUAL REPORT MEDICAL (P.D.)
KIDNEY DIALYSIS FOUNDATION ANNUAL REPORT MEDICAL (P.D.) 2005 Prepared by Dr Grace Lee Medical Director With input from: Theresa Soh Manager, Patient Services Wu Sin Yan Charge Nurse TABLE OF CONTENTS 1.
More informationHEALTHYSTART TRAINING MANUAL. Living well with Kidney Disease
HEALTHYSTART TRAINING MANUAL Living well with Kidney Disease KIDNEY DISEASE CAN AFFECT ANYONE! 1 HEALTHYSTART PROGRAMME HEALTHYSTART is a lifestyle management programme to assist you to remain healthy
More informationRenal Transplant Registry Report 2008
Renal Transplant Registry Report 28 Contents:. Introduction Page 2. Summary of transplant activity 27-28 Page 2 3. Graft and Patient Survival analysis 989-28 Page 3 4. Acute rejection 989-28 Page 24. Comparison
More informationPatient Education Programme. Kidney Options Guiding you when kidneys fail
Patient Education Programme Kidney Options Guiding you when kidneys fail About the kidneys What do healthy kidneys do? Your two kidneys work more than you realise. The kidneys remove excess body water
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease
More informationClinical Study Results in Assisted Peritoneal Dialysis: A Ten-Year Experience
International Nephrology Volume 2015, Article ID 712539, 5 pages http://dx.doi.org/10.1155/2015/712539 Clinical Study Results in Assisted Peritoneal Dialysis: A Ten-Year Experience Sara Querido, 1 Patrícia
More informationVolume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients
Volume Management Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 14, 2017 Disclosures statement: Consultant: Allena, Becker Professional Education Grant
More informationUpdate in Peritoneal dialysis
Update in Peritoneal dialysis Matthew Jose MBBS, FRACP, PhD, FASN, AFRACMA Royal Hobart Hospital FACULTY OF HEALTH I pay my respects to the traditional owners of this land, the Larrakia people, and to
More informationPERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE
PERITONEAL DIALYSIS PRESCRIPTION MANAGEMENT QUICK REFERENCE GUIDE This quick reference guide will help serve as a reference tool for clinicians setting a patient s Peritoneal Dialysis (PD) prescription.
More information3/5/18. Background. Registry Reports. Dialysis Registry Update and Future Directions
Dialysis Registry Update and Future Directions Annabelle N. Chua, MD March 4, 2018 Background Founded in 1987 as a transplant registry Expanded registry to include dialysis (1992) and CKD (1994) Patient
More information